Combination of radiotherapy and targeted therapy for HER2-positive breast cancer brain metastases
Last Updated: Friday, July 17, 2026
This review article discusses the use of combination radiotherapy and targeted therapy for HER2+ breast cancer brain metastases, including the benefits and potential risks, efficacy, side effects, and time sequence and selection of specific therapies.